Showing results (111-120 of 175) with videos related to
Sort By:
Pageof 18
Gynecologic Oncology|July 1, 1984
A clinical and pathologic study of 30 cases of malignant mixed mullerian epithelial and mesenchymal ovarian tumors: a Gynecologic Oncology Group studyC P Morrow, G d'Ablaing, L W Brady, et al.Gynecologic Oncology|November 1, 1988
Hexamethylmelamine as first-line chemotherapy in the treatment of advanced or recurrent carcinoma of the endometrium: a phase II trial of the Gynecologic Oncology GroupJ T Thigpen, J A Blessing, H Ball, et al.Cancer|November 1, 1987
Single-dose actinomycin-D treatment for nonmetastatic gestational trophoblastic disease. A prospective phase II trial of the Gynecologic Oncology GroupE S Petrilli, L B Twiggs, J A Blessing, et al.American Journal of Clinical Oncology|October 1, 1985
Phase II trial of piperazinedione in patients with advanced or recurrent uterine sarcoma. A Gynecologic Oncology Group studyJ T Thigpen, J A Blessing, H D Homesley, et al.American Journal of Clinical Oncology|June 1, 1983
Phase II study of maytansine in the treatment of advanced or recurrent adenocarcinoma of the ovary. A Gynecologic Oncology Group studyJ T Thigpen, C E Ehrlich, W T Creasman, et al.American Journal of Clinical Oncology|December 1, 1993
Circadian-timed combination doxorubicin-cisplatin chemotherapy for advanced endometrial carcinoma. A phase II study of the Gynecologic Oncology GroupR J Barrett, J A Blessing, H D Homesley, et al.Gynecologic Oncology|June 1, 2000
Topotecan in squamous cell carcinoma of the cervix: A Phase II study of the Gynecologic Oncology GroupM A Bookman, J A Blessing, P Hanjani, et al.Cancer|March 1, 1985
Retiform differentiation in ovarian Sertoli-Leydig cell tumors. A clinicopathologic study of six cases from a Gynecologic Oncology Group studyL M Roth, R E Slayton, L W Brady, et al.American Journal of Clinical Oncology|August 1, 1986
Aminothiadiazole (NSC 4728) in patients with advanced ovarian carcinoma. A phase II study of the Gynecologic Oncology GroupR F Asbury, J Wilson, J A Blessing, et al.Cancer Chemotherapy and Pharmacology|January 1, 1990
Early phase II Gynecologic Oncology Group experience with ifosfamide/mesna in gynecologic malignanciesG P Sutton, J A Blessing, G Photopulos, et al.Pageof 18